Menu

Month: October 2024

Exclusive

Former Senior Trump Official Talks Drug Pricing Reform, Says 340B Program Is ‘Out of Control’

Bella Czajkowski, National Correspondent Views
Joe Grogan (left), a top official in the former Trump administration raised serious concerns with the 340B program during the keynote address at The Association for Value-Based Cancer Care Annual Summit in New York Thursday.
A key official in the former Trump administration raised serious concerns with the 340B program during the keynote address at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended

Bella Czajkowski, National Correspondent Views
J&J's proposed rebate model was a key topic of discussion at a Wednesday panel led by moderator, 340B Report Publisher and CEO Ted Slafsky.
An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Dark Money Poured Nearly $4M into Super PAC Opposing State 340B Contract Pharmacy Access Bills

William Newton, Associate Editor/Senior Writer Views
Stand for US PAC received $3.8 million in contributions over the last three months from a conservative dark money group.
A political action committee (PAC) that funded efforts opposing state 340B contract pharmacy access bills through misleading claims linking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

LA Times Says ‘No’ to California Ballot Measure That Would Affect 340B 

Shannon Young, Associate Editor/Senior Writer Views
The Los Angeles Times’ editorial board endorsed the “no” position on Proposition 34, a 340B-realated measure which will appear on the Nov. 5 ballot.
An influential California newspaper recently urged against a November ballot measure, which would require certain healthcare providers in the state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: New Filings in Missouri, Minnesota

William Newton and Shannon Young, Associate Editor/Senior Writer Views
Key motions were recently filed in state contract pharmacy litigation in Missouri and Minnesota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

PhRMA Pans Government’s Response to J&J’s 340B Rebate Proposal in Letter to HRSA Administrator

William Newton, Associate Editor/Senior Writer Views
PhRMA sent an Oct. 11 letter to HRSA criticizing the agency's opposition to J&J's 340B rebate proposal.
Pharmaceutical Research and Manufacturers of America (PhRMA) expressed “serious concerns” with the federal government’s opposition to Johnson & Johnson’s (J&J’s) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

340B Health Leader Slams J&J Rebate Proposal, Urges Providers to ‘Remain Vigilant’ in Op-Ed

Shannon Young, Associate Editor/Senior Writer Views
Maureen Testoni, the president and CEO of 340B Health celebrated J&J’s retreat from a 340B rebate proposal in an Oct. 9 RACmonitor op-ed.
The head of an influential 340B hospital advocacy group claimed “victory” in the recent fight against Johnson & Johnson’s (J&J) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Providers Raise Caution on Claims Data Submission Requirements After 340B ESP Terms of Use Update Continues to Defer to Manufacturers

Shannon Young, Associate Editor/Senior Writer Views
Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.
Editor’s Note: An earlier version of this story incorrectly suggested that an Oct. 4 update to 340B ESP’s terms of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Health Centers Urge Federal Appeals Court to Take Their Side in Case Alleging Drug Manufacturer Collusion on Contract Pharmacy Restrictions

Bella Czajkowski, National Correspondent Views
Two community health centers argued in a Sept. 30 filing with the U.S. 2nd Circuit Court of Appeals that diabetes drugmakers colluded to place contract pharmacy restrictions.
Two community health centers urged a federal appeals court to overturn the dismissal of their 340B antitrust lawsuit, arguing in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

CMS Inaction on IRA-340B Conflicts May Drive ‘Manufacturer-Friendly’ Compliance Models

William Newton, Associate Editor/Senior Writer Views
340B-IRA interactions
CMS has not assumed responsibility for “deduplicating” discounts that arise between the 340B program and the IRA's Medicare drug price negotiations.
Federal regulators’ inaction on the 340B program’s interactions with Medicare drug price negotiations will likely lead drugmakers to pursue “manufacturer-friendly” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live